In strengthening their activities, there are a number of strategic benefits companies can achieve in pharmaceutical production by transferring production between sites. For various reasons, the transfer of production -and the underlying technologies- can be risky.
The pharmaceutical company must take into account 4 important elements before starting the Technology Transfer process:
1. Risk assessment and development of mitigation plans prior to transfer
2. Troubleshooting prior to transfer
3. Standardization of processes and equipment
4. Equal attention to people as to processes
A consistent, risk-based approach, updated with quality data through the design and design of experimental initiatives, will improve the industry's ability to efficiently, effectively and seamlessly transfer production in the future.
Source: Pharmaceutical Online